Head to Head Contrast: Hawaiian Macadamia Nut Orchards (OTCMKTS:NNUTU) & TerrAscend (OTCMKTS:TSNDF)

TerrAscend (OTCMKTS:TSNDFGet Free Report) and Hawaiian Macadamia Nut Orchards (OTCMKTS:NNUTUGet Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Insider and Institutional Ownership

0.0% of TerrAscend shares are owned by institutional investors. 32.9% of TerrAscend shares are owned by insiders. Comparatively, 7.9% of Hawaiian Macadamia Nut Orchards shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent recommendations for TerrAscend and Hawaiian Macadamia Nut Orchards, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TerrAscend 0 0 0 0 N/A
Hawaiian Macadamia Nut Orchards 0 0 0 0 N/A

TerrAscend currently has a consensus price target of $2.50, indicating a potential upside of 47.93%. Given TerrAscend’s higher possible upside, research analysts plainly believe TerrAscend is more favorable than Hawaiian Macadamia Nut Orchards.

Profitability

This table compares TerrAscend and Hawaiian Macadamia Nut Orchards’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
TerrAscend -131.93% -1.44% -0.61%
Hawaiian Macadamia Nut Orchards N/A N/A N/A

Valuation & Earnings

This table compares TerrAscend and Hawaiian Macadamia Nut Orchards’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
TerrAscend $247.83 million 1.96 -$329.91 million N/A N/A
Hawaiian Macadamia Nut Orchards N/A N/A N/A N/A N/A

Hawaiian Macadamia Nut Orchards has lower revenue, but higher earnings than TerrAscend.

Volatility and Risk

TerrAscend has a beta of 2.78, indicating that its share price is 178% more volatile than the S&P 500. Comparatively, Hawaiian Macadamia Nut Orchards has a beta of -869.32, indicating that its share price is 87,032% less volatile than the S&P 500.

Summary

TerrAscend beats Hawaiian Macadamia Nut Orchards on 5 of the 8 factors compared between the two stocks.

About TerrAscend

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

About Hawaiian Macadamia Nut Orchards

(Get Free Report)

Hawaiian Macadamia Nut Orchards LP engages in producing and distributing macadamia nut-based products. It operates through the Orchards and Branded Products segments. The Orchards segment includes the sale of wet-in-shell macadamia nuts, sale of dry-in-shell macadamia nuts, and sale of macadamia nut kernel. The Branded Products segment refers to the sale of bulk macadamia nut kernel and branded macadamia nut products. The company was founded in June 1986 and is headquartered in Hilo, HI.

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.